Windtree Therapeutics Inc (WINT)
4.49
+0.19
(+4.42%)
USD |
NASDAQ |
May 17, 16:00
4.41
-0.08
(-1.78%)
After-Hours: 20:00
Windtree Therapeutics Cash and Short Term Investments (Quarterly): 4.319M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.319M |
| September 30, 2023 | 7.365M |
| June 30, 2023 | 11.47M |
| March 31, 2023 | 4.235M |
| December 31, 2022 | 6.172M |
| September 30, 2022 | 8.436M |
| June 30, 2022 | 11.38M |
| March 31, 2022 | 15.54M |
| December 31, 2021 | 22.35M |
| September 30, 2021 | 24.54M |
| June 30, 2021 | 29.96M |
| March 31, 2021 | 38.49M |
| December 31, 2020 | 16.93M |
| September 30, 2020 | 22.36M |
| June 30, 2020 | 31.52M |
| March 31, 2020 | 16.80M |
| December 31, 2019 | 22.58M |
| September 30, 2019 | 4.437M |
| June 30, 2019 | 8.664M |
| March 31, 2019 | 15.57M |
| December 31, 2018 | 25.15M |
| September 30, 2018 | 0.64M |
| June 30, 2018 | 0.638M |
| March 31, 2018 | 1.854M |
| December 31, 2017 | 1.815M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.752M |
| June 30, 2017 | 2.528M |
| March 31, 2017 | 8.022M |
| December 31, 2016 | 5.588M |
| September 30, 2016 | 12.38M |
| June 30, 2016 | 20.33M |
| March 31, 2016 | 29.40M |
| December 31, 2015 | 38.72M |
| September 30, 2015 | 46.31M |
| June 30, 2015 | 26.09M |
| March 31, 2015 | 35.58M |
| December 31, 2014 | 44.71M |
| September 30, 2014 | 54.92M |
| June 30, 2014 | 65.56M |
| March 31, 2014 | 75.94M |
| December 31, 2013 | 86.28M |
| September 30, 2013 | 21.18M |
| June 30, 2013 | 31.25M |
| March 31, 2013 | 26.37M |
| December 31, 2012 | 26.89M |
| September 30, 2012 | 36.06M |
| June 30, 2012 | 46.01M |
| March 31, 2012 | 54.80M |
| December 31, 2011 | 10.19M |
| September 30, 2011 | 15.41M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
4.235M
Minimum
Mar 2023
38.49M
Maximum
Mar 2021
16.19M
Average
15.54M
Median
Mar 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | 355.60M |
| AIM ImmunoTech Inc | 13.07M |
| Perspective Therapeutics Inc | 180.65M |
| Protalix BioTherapeutics Inc | 48.49M |
| Armata Pharmaceuticals Inc | 37.86M |